← Leaderboards
Susan E Dorman
Johns Hopkins University
$18,489,626
Attributed
$39,688,051
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$36,400,393 · 10
FDA$3,287,658 · 2
By mechanism
U01$19,752,680 · 1
R01$17,601,483 · 6
K24$790,188 · 1
K23$657,450 · 1
R21$489,492 · 1
R34$240,878 · 1
Top collaborators
- David Alland17 shared
- Jerrold J. Ellner12 shared
- Kelly E. Dooley5 shared
- Basil I. Swanson3 shared
- Morten Ruhwald1 shared
- Kevin Loring Winthrop1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Darrell J. Gaskin$7,194,768
- Ying Zhang$6,675,418
- Robert H Gilman$35,342,766
- Eric L Nuermberger$20,859,483
- Peter M. Abadir$6,408,859
Others in their field
Top investigators on “Tuberculosis”
- Judith S. Currier · University Of California Los Angeles$301,722,065
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
- Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,192,298
- Sharon A Nachman · Johns Hopkins University$194,852,226
Research focus
TuberculosisMycobacterium TuberculosisPharmaceutical PreparationsTuberculosis TreatmentDiagnosticFutureDiagnosisProgramsLaboratoriesFundingCommunicable DiseasesUnited States National Institutes Of HealthCostDetectionSputumDiagnostic TestsBaseDiagnostics ResearchPredispositionPulmonary TuberculosisSpecimenEvaluationCharacteristicsDesign
Grant awards (48)
FEND-TB$2,593,818
R01 · FY2025 · AI
FEND-TB$298,587
R01 · FY2025 · AI
Novel strategies for treatment of Mycobacterium abscessus pulmonary disease$240,878
R34 · FY2025 · AI · contact PI
FEND-TB$196,955
R01 · FY2025 · AI
FEND for TB$3,689,474
U01 · FY2024 · AI
FEND for TB$3,943,297
U01 · FY2023 · AI
FEND for TB$4,167,230
U01 · FY2022 · AI
FEND for TB$3,954,651
U01 · FY2021 · AI
Phase 2 Study of PA-824 for Treatment of Pulmonary Tuberculosis$100,000
R01 · FY2021 · FD
FEND for TB$3,998,028
U01 · FY2020 · AI
Novel Biomarkers to Shorten TB Treatment$659,830
R01 · FY2020 · AI
Accuracy of the Xpert Ultra for Diagnosis of Pulmonary Tuberculosis$556,523
R01 · FY2020 · AI · contact PI
Accuracy of the Xpert Ultra for Diagnosis of Pulmonary Tuberculosis$1,180,603
R01 · FY2019 · AI · contact PI
Novel Biomarkers to Shorten TB Treatment$709,366
R01 · FY2019 · AI
Multidisciplinary Clinical Research and Mentoring in Tuberculosis Diagnostics$157,476
K24 · FY2019 · AI · contact PI
Accuracy of the Xpert Ultra for Diagnosis of Pulmonary Tuberculosis$1,325,755
R01 · FY2018 · AI · contact PI
Novel Biomarkers to Shorten TB Treatment$725,266
R01 · FY2018 · AI
Phase 2 Study of PA-824 for Treatment of Pulmonary Tuberculosis$400,000
R01 · FY2018 · FD
Multidisciplinary Clinical Research and Mentoring in Tuberculosis Diagnostics$157,476
K24 · FY2018 · AI · contact PI
Accuracy of the Xpert Ultra for Diagnosis of Pulmonary Tuberculosis$1,424,115
R01 · FY2017 · AI · contact PI
Novel Biomarkers to Shorten TB Treatment$728,068
R01 · FY2017 · AI
Phase 2 Study of PA-824 for Treatment of Pulmonary Tuberculosis$400,000
R01 · FY2017 · FD
Multidisciplinary Clinical Research and Mentoring in Tuberculosis Diagnostics$83,934
K24 · FY2017 · AI · contact PI
Multidisciplinary Clinical Research and Mentoring in Tuberculosis Diagnostics$73,542
K24 · FY2017 · AI · contact PI
Novel Biomarkers to Shorten TB Treatment$672,409
R01 · FY2016 · AI
Multidisciplinary Clinical Research and Mentoring in Tuberculosis Diagnostics$157,476
K24 · FY2016 · AI · contact PI
Phase 2 Study of PA-824 for Treatment of Pulmonary Tuberculosis$400,000
R01 · FY2015 · FD
Lipidated Mycobacterium tuberculosis biomarkers in clinical specimens$226,328
R21 · FY2015 · AI · contact PI
Multidisciplinary Clinical Research and Mentoring in Tuberculosis Diagnostics$160,284
K24 · FY2015 · AI · contact PI
Phase 2 Study of PA-824 for Treatment of Pulmonary Tuberculosis$400,000
R01 · FY2014 · FD
Lipidated Mycobacterium tuberculosis biomarkers in clinical specimens$1
R21 · FY2014 · AI · contact PI
Lipidated Mycobacterium tuberculosis biomarkers in clinical specimens$263,163
R21 · FY2013 · AI · contact PI
Extensively Drug-Resistant Tuberculosis Among Gold Miners in South Africa$682,980
R01 · FY2012 · AI · contact PI
Phase II Study of Daily Rifapentine for Pulmonary Tuberculosis (IND 62,611; 1/2/0$387,658
R01 · FY2012 · FD · contact PI
Extensively Drug-Resistant Tuberculosis Among Gold Miners in South Africa$660,654
R01 · FY2011 · AI · contact PI
Phase II Study of Daily Rifapentine for Pulmonary Tuberculosis (IND 62,611; 1/2/0$400,000
R01 · FY2011 · FD · contact PI
Extensively Drug-Resistant Tuberculosis Among Gold Miners in South Africa$608,927
R01 · FY2010 · AI · contact PI
Phase II Study of Daily Rifapentine for Pulmonary Tuberculosis (IND 62,611; 1/2/0$400,000
R01 · FY2010 · FD · contact PI
Extensively Drug-Resistant Tuberculosis Among Gold Miners in South Africa$620,472
R01 · FY2009 · AI · contact PI
Phase II Study of Daily Rifapentine for Pulmonary Tuberculosis (IND 62,611; 1/2/0$400,000
R01 · FY2009 · FD · contact PI
Extensively Drug-Resistant Tuberculosis Among Gold Miners in South Africa$669,497
R01 · FY2008 · AI · contact PI
Rapid Detection of Mycobacterium tuberculosis$131,490
K23 · FY2007 · AI · contact PI
Rapid Detection of Mycobacterium tuberculosis$131,490
K23 · FY2006 · AI · contact PI
Rapid Detection of Mycobacterium tuberculosis$131,490
K23 · FY2005 · AI
Rapid Detection of Mycobacterium tuberculosis$131,490
K23 · FY2004 · AI
Mycobacterium tuberculosis cell wall virulence factors$78,575
R03 · FY2004 · AI
Rapid Detection of Mycobacterium tuberculosis$131,490
K23 · FY2003 · AI
Mycobacterium tuberculosis cell wall virulence factors$77,305
R03 · FY2003 · AI